NVCT
Nuvectis Pharma Inc
NASDAQ: NVCT · HEALTHCARE · BIOTECHNOLOGY
$10.00
+2.99% today
Updated 2026-05-06
Market cap
$268.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.31
Dividend yield
—
52W range
$6 – $11
Volume
0.1M
Nuvectis Pharma Inc (NVCT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $24000.00 | $-9.50M | $-13.56M | $-15.95M | $-12.25M | $-16.01M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | — | $1.89M | $1.71M | $4.71M | $4.86M | $1.35M |
| Free cash flow | $24000.00 | $-9.50M | $-13.56M | $-15.95M | $-12.25M | $-16.01M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | $14.25M | — | — | — |